Invexans Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Invexans.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Electrical earnings growth | 23.0% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | None |
Last updated | n/a |
Recent future growth updates
No updates
Recent updates
Invexans (SNSE:INVEXANS) Is Looking To Continue Growing Its Returns On Capital
Sep 23The Return Trends At Invexans (SNSE:INVEXANS) Look Promising
Apr 29Invexans (SNSE:INVEXANS) Is Doing The Right Things To Multiply Its Share Price
Aug 27Here's Why Invexans (SNSE:INVEXANS) Can Manage Its Debt Responsibly
Oct 30We Think Invexans (SNSE:INVEXANS) Is Taking Some Risk With Its Debt
May 06Invexans (SNSE:INVEXANS) Posted Healthy Earnings But There Are Some Other Factors To Be Aware Of
Apr 01Returns On Capital Are Showing Encouraging Signs At Invexans (SNSE:INVEXANS)
Mar 30Introducing Invexans (SNSE:INVEXANS), The Stock That Zoomed 155% In The Last Year
Feb 16Would Invexans (SNSE:INVEXANS) Be Better Off With Less Debt?
Dec 23In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Invexans has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
6/30/2023 | 5,652 | 243 | -1 | 145 | N/A |
3/31/2023 | 5,451 | 158 | -60 | 86 | N/A |
12/31/2022 | 5,125 | 168 | -68 | 79 | N/A |
9/30/2022 | 4,821 | 183 | -63 | 64 | N/A |
6/30/2022 | 4,544 | 179 | -41 | 80 | N/A |
3/31/2022 | 4,172 | 141 | 40 | 146 | N/A |
12/31/2021 | 3,804 | 135 | 115 | 191 | N/A |
9/30/2021 | 3,401 | 148 | 159 | 229 | N/A |
6/30/2021 | 2,967 | 123 | 210 | 274 | N/A |
3/31/2021 | 2,627 | 37 | 118 | 172 | N/A |
12/31/2020 | 1,833 | 16 | 94 | 141 | N/A |
9/30/2020 | 1,132 | -47 | 48 | 77 | N/A |
6/30/2020 | 539 | -42 | -25 | -13 | N/A |
3/31/2020 | 0 | -46 | 0 | 0 | N/A |
12/31/2019 | 0 | -46 | 0 | 0 | N/A |
9/30/2019 | 0 | -55 | 0 | 0 | N/A |
6/30/2019 | 0 | -57 | -3 | -3 | N/A |
3/31/2019 | 0 | -14 | 1 | 1 | N/A |
12/31/2018 | 0 | -13 | 2 | 2 | N/A |
9/30/2018 | N/A | 9 | 2 | 2 | N/A |
6/30/2018 | N/A | 10 | 5 | 5 | N/A |
3/31/2018 | N/A | 34 | 2 | 2 | N/A |
12/31/2017 | 0 | 36 | 2 | 2 | N/A |
9/30/2017 | 0 | 33 | 2 | 2 | N/A |
6/30/2017 | 0 | 35 | 2 | 2 | N/A |
3/31/2017 | 0 | 16 | N/A | -4 | N/A |
12/31/2016 | 0 | 13 | N/A | -3 | N/A |
9/30/2016 | 0 | -28 | N/A | -3 | N/A |
6/30/2016 | 0 | -29 | N/A | -4 | N/A |
3/31/2016 | 0 | -59 | N/A | -4 | N/A |
12/31/2015 | 0 | -64 | N/A | -4 | N/A |
9/30/2015 | 0 | -95 | N/A | -6 | N/A |
6/30/2015 | 0 | -104 | N/A | -6 | N/A |
3/31/2015 | 1 | -78 | N/A | -7 | N/A |
12/31/2014 | 1 | -74 | N/A | -7 | N/A |
9/30/2014 | 1 | -62 | N/A | -9 | N/A |
6/30/2014 | 1 | -53 | N/A | -8 | N/A |
3/31/2014 | 1 | -93 | N/A | -3 | N/A |
12/31/2013 | 1 | -93 | N/A | 1 | N/A |
9/30/2013 | 1 | -28 | N/A | 4 | N/A |
6/30/2013 | 0 | -33 | N/A | 9 | N/A |
3/31/2013 | 0 | 10 | N/A | 8 | N/A |
12/31/2012 | 0 | 44 | N/A | 12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if INVEXANS's forecast earnings growth is above the savings rate (4.5%).
Earnings vs Market: Insufficient data to determine if INVEXANS's earnings are forecast to grow faster than the CL market
High Growth Earnings: Insufficient data to determine if INVEXANS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if INVEXANS's revenue is forecast to grow faster than the CL market.
High Growth Revenue: Insufficient data to determine if INVEXANS's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if INVEXANS's Return on Equity is forecast to be high in 3 years time